A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats

被引:44
作者
Peters, CT
Choi, YH
Brubaker, PL
Anderson, GH [1 ]
机构
[1] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada
关键词
gut peptide; high protein; low carbohydrate diet; intraperitoneal administration; protein-free; high carbohydrate diet; rats;
D O I
10.1093/jn/131.8.2164
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The hypothesis that peripheral glucagon-like peptide-1 (GLP-1) is a regulator of both food intake and macronutrient selection in rats was tested by administration of its antagonist, exendin 9-39, and its agonist, exendin 4. The effect of exendin 9-39 given intraperitoneally (i.p.) on food Intake was measured after carbohydrate, protein or fat preloads, and on choice between a protein-free, high carbohydrate (CHO) diet and a high protein, low carbohydrate (PRO) diet. The effect of exendin 4 on selection between the CHO and PRO diets was also investigated. Exendin 9-39 significantly enhanced food intake suppression occurring after glucose, but not after corn oil or albumin preloads. In diet selection studies, exendin 9-39 selectively decreased intake of only the CHO diet. In contrast, exendin 4 decreased intake of only the PRO diet. Thus, we suggest that peripheral GLP-1 plays a role in the regulation of macronutrient selection as well as food intake in rats.
引用
收藏
页码:2164 / 2170
页数:7
相关论文
共 38 条
[1]  
Anderson GH, 1994, MODERN NUTR HLTH DIS, P524
[2]   An interaction between hypothalamic glucagon-like peptide-1 and macronutrient composition determines food intake in rats [J].
Choi, YH ;
Anderson, GH .
JOURNAL OF NUTRITION, 2001, 131 (06) :1819-1825
[3]   Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats [J].
de Fonseca, FR ;
Navarro, M ;
Alvarez, E ;
Roncero, I ;
Chowen, JA ;
Maestre, O ;
Gómez, R ;
Muñoz, RM ;
Eng, J ;
Blázquez, E .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (06) :709-717
[4]   BOTH SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED GLUCAGON-LIKE PEPTIDE-I ARE RAPIDLY DEGRADED FROM THE NH2-TERMINUS IN TYPE-II DIABETIC-PATIENTS AND IN HEALTHY-SUBJECTS [J].
DEACON, CF ;
NAUCK, MA ;
TOFTNIELSEN, M ;
PRIDAL, L ;
WILLMS, B ;
HOLST, JJ .
DIABETES, 1995, 44 (09) :1126-1131
[5]   Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats [J].
Donahey, JCK ;
van Dijk, G ;
Woods, SC ;
Seeley, RJ .
BRAIN RESEARCH, 1998, 779 (1-2) :75-83
[6]   THE INFLUENCE OF DIFFERENT NUTRIENTS ON PLASMA CHOLECYSTOKININ LEVELS IN THE RAT [J].
DOUGLAS, BR ;
WOUTERSEN, RA ;
JANSEN, JBMJ ;
DEJONG, AJL ;
LAMERS, CBHW .
EXPERIENTIA, 1988, 44 (01) :21-23
[7]   Glucagon-like peptides [J].
Drucker, DJ .
DIABETES, 1998, 47 (02) :159-169
[8]   Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans - Studies with the antagonist exendin 9-39 [J].
Edwards, CMB ;
Todd, JF ;
Mahmoudi, M ;
Wang, ZL ;
Wang, RM ;
Ghatei, MA ;
Bloom, SR .
DIABETES, 1999, 48 (01) :86-93
[9]   Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans [J].
Flint, A ;
Raben, A ;
Astrup, A ;
Holst, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (03) :515-520
[10]  
FRIEDMAN MI, 1995, AM J CLIN NUTR, V62, P1096